
Entegris (ENTG) | Financial Analysis & Statements
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Mar 2025Income Metrics
Revenue
773.2M
Gross Profit
356.5M
46.11%
Operating Income
122.3M
15.82%
Net Income
62.9M
8.14%
EPS (Diluted)
$0.41
Balance Sheet Metrics
Total Assets
8.4B
Total Liabilities
4.7B
Shareholders Equity
3.7B
Debt to Equity
1.25
Cash Flow Metrics
Operating Cash Flow
140.4M
Free Cash Flow
32.4M
Revenue & Profitability Trend
Entegris Income Statement From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Revenue | 3.2B | 3.5B | 3.3B | 2.3B | 1.9B |
Cost of Goods Sold | 1.8B | 2.0B | 1.9B | 1.2B | 1.0B |
Gross Profit | 1.5B | 1.5B | 1.4B | 1.1B | 849.7M |
Gross Margin % | 45.9% | 42.5% | 42.5% | 46.1% | 45.7% |
Operating Expenses | |||||
Research & Development | 316.1M | 277.3M | 229.0M | 167.6M | 136.1M |
Selling, General & Administrative | 553.3M | 426.2M | 543.5M | 292.4M | 265.1M |
Other Operating Expenses | - | - | - | - | - |
Total Operating Expenses | 869.4M | 703.5M | 772.5M | 460.0M | 401.2M |
Operating Income | 435.1M | 579.6M | 480.0M | 551.8M | 395.4M |
Operating Margin % | 13.4% | 16.4% | 14.6% | 24.0% | 21.3% |
Non-Operating Items | |||||
Interest Income | 7.4M | 11.3M | 3.7M | 243.0K | 786.0K |
Interest Expense | 215.2M | 312.4M | 212.7M | 41.2M | 48.6M |
Other Non-Operating Income | 94.8M | -105.8M | -23.9M | -31.7M | 6.7M |
Pre-tax Income | 322.1M | 172.7M | 247.1M | 479.1M | 354.3M |
Income Tax | 28.3M | -8.4M | 38.2M | 70.0M | 59.3M |
Effective Tax Rate % | 8.8% | -4.9% | 15.4% | 14.6% | 16.7% |
Net Income | 292.8M | 180.7M | 208.9M | 409.1M | 295.0M |
Net Margin % | 9.0% | 5.1% | 6.4% | 17.8% | 15.9% |
Key Metrics | |||||
EBITDA | 818.7M | 977.4M | 765.4M | 689.7M | 532.0M |
EPS (Basic) | $1.94 | $1.21 | $1.47 | $3.02 | $2.19 |
EPS (Diluted) | $1.93 | $1.20 | $1.46 | $3.00 | $2.16 |
Basic Shares Outstanding | 150946000 | 149900000 | 142294000 | 135411000 | 134837000 |
Diluted Shares Outstanding | 150946000 | 149900000 | 142294000 | 135411000 | 134837000 |
Income Statement Trend
Entegris Balance Sheet From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Assets | |||||
Current Assets | |||||
Cash & Equivalents | 329.2M | 456.9M | 561.6M | 402.6M | 580.9M |
Short-term Investments | - | - | - | - | - |
Accounts Receivable | 497.3M | 457.6M | 536.3M | 347.1M | 264.8M |
Inventory | 638.1M | 607.1M | 812.8M | 475.2M | 323.9M |
Other Current Assets | 108.6M | 113.7M | 129.3M | 52.9M | 43.9M |
Total Current Assets | 1.6B | 2.0B | 2.3B | 1.3B | 1.2B |
Non-Current Assets | |||||
Property, Plant & Equipment | 1.2B | 1.0B | 909.1M | 702.3M | 607.8M |
Goodwill | 9.0B | 9.2B | 10.7B | 1.9B | 1.8B |
Intangible Assets | 1.1B | 1.3B | 1.8B | 335.1M | 337.6M |
Long-term Investments | - | - | - | - | - |
Other Non-Current Assets | 36.6M | 59.0M | 65.1M | 29.0M | 26.5M |
Total Non-Current Assets | 6.8B | 6.8B | 7.8B | 1.9B | 1.7B |
Total Assets | 8.4B | 8.8B | 10.1B | 3.2B | 2.9B |
Liabilities | |||||
Current Liabilities | |||||
Accounts Payable | 193.3M | 134.2M | 172.5M | 130.7M | 81.6M |
Short-term Debt | - | - | 152.0M | - | - |
Current Portion of Long-term Debt | - | - | - | - | - |
Other Current Liabilities | 1.2M | 19.2M | 10.6M | - | - |
Total Current Liabilities | 525.2M | 514.0M | 761.9M | 379.0M | 302.6M |
Non-Current Liabilities | |||||
Long-term Debt | 4.1B | 4.6B | 5.7B | 997.1M | 1.1B |
Deferred Tax Liabilities | 70.2M | 190.1M | 391.2M | 64.2M | 73.6M |
Other Non-Current Liabilities | - | - | - | - | - |
Total Non-Current Liabilities | 4.2B | 4.9B | 6.2B | 1.1B | 1.2B |
Total Liabilities | 4.7B | 5.4B | 6.9B | 1.5B | 1.5B |
Equity | |||||
Common Stock | 1.5M | 1.5M | 1.5M | 1.4M | 1.4M |
Retained Earnings | 1.4B | 1.2B | 1.0B | 879.8M | 577.8M |
Treasury Stock | 7.1M | 7.1M | 7.1M | 7.1M | 7.1M |
Other Equity | - | - | - | - | - |
Total Shareholders Equity | 3.7B | 3.4B | 3.2B | 1.7B | 1.4B |
Key Metrics | |||||
Total Debt | 4.1B | 4.6B | 5.9B | 997.1M | 1.1B |
Working Capital | 1.1B | 1.5B | 1.6B | 934.4M | 931.6M |
Balance Sheet Composition
Entegris Cash Flow Statement From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Operating Activities | |||||
Net Income | 292.8M | 180.7M | 208.9M | 409.1M | 295.0M |
Depreciation & Amortization | 378.2M | 387.2M | 279.3M | 138.2M | 136.5M |
Stock-Based Compensation | 65.9M | 61.4M | 66.6M | 29.9M | 22.9M |
Working Capital Changes | -109.0M | 60.7M | -260.1M | -193.4M | -47.8M |
Operating Cash Flow | 609.7M | 442.4M | 327.2M | 380.4M | 415.8M |
Investing Activities | |||||
Capital Expenditures | -315.6M | -456.8M | -466.2M | -210.6M | -131.8M |
Acquisitions | 250.8M | 815.0M | -4.5B | -91.9M | -111.9M |
Investment Purchases | - | - | - | - | - |
Investment Sales | - | - | - | - | - |
Investing Cash Flow | -67.1M | 553.1M | -4.9B | -298.1M | -243.3M |
Financing Activities | |||||
Share Repurchases | - | 0 | 0 | -67.1M | -44.6M |
Dividends Paid | -60.6M | -60.2M | -57.3M | -43.5M | -43.2M |
Debt Issuance | 364.5M | 217.4M | 5.4B | 501.0M | 400.0M |
Debt Repayment | -988.3M | -1.5B | -486.0M | -651.0M | -468.0M |
Financing Cash Flow | -703.0M | -1.5B | 4.9B | -301.2M | -203.6M |
Free Cash Flow | 316.1M | 172.7M | -113.9M | 189.8M | 314.9M |
Net Change in Cash | -160.4M | -473.0M | 266.6M | -219.0M | -31.1M |
Cash Flow Trend
Entegris Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
40.21
Forward P/E
20.42
Price to Book
3.12
Price to Sales
3.68
PEG Ratio
-1.81
Profitability Ratios
Profit Margin
9.17%
Operating Margin
15.07%
Return on Equity
8.08%
Return on Assets
3.95%
Financial Health
Current Ratio
3.30
Debt to Equity
106.49
Beta
1.22
Per Share Data
EPS (TTM)
$1.95
Book Value per Share
$25.16
Revenue per Share
$21.30
Peer Financial Comparison
Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
---|---|---|---|---|---|---|
entg | 11.9B | 40.21 | 3.12 | 8.08% | 9.17% | 106.49 |
Applied Materials | 128.3B | 19.07 | 6.54 | 35.63% | 23.88% | 32.11 |
Lam Research | 125.1B | 23.82 | 12.72 | 58.24% | 29.07% | 48.23 |
KLA | 115.6B | 28.82 | 24.65 | 100.78% | 33.41% | 129.75 |
Teradyne | 17.6B | 38.41 | 6.21 | 16.85% | 16.59% | 2.62 |
Nova | 7.3B | 33.88 | 6.69 | 24.23% | 29.10% | 19.08 |
Financial data is updated regularly. All figures are in the company's reporting currency.